First Round of Abstract Submission : July 01, 2020 | Welcome Message

Theme : Innovations and Novel Approaches in Diagnosis and Treatment of Breast Cancer and Women’s Health

Organizing Committee Members


Amiable welcome from Science Access to participants, from all around the world to attend the “4th World Congress on Breast Cancer and Women’s Health” during  May 24-26, 2021. The Breast Cancer 2021 gatherings intend to investigate the crown examines in the tremendous field of science and united sciences.

Breast cancer is a disease which occurs when cells in the breast tissue change or mutate and keep reproducing. These irregular (abnormal cells) usually cluster together to form a tumor. This cancerous or malignant tumor invades other parts of the breast or when they spread (or metastasize) to other areas of the body through the lymphatic system or bloodstream. Breast cancer is caused by a genetic transformation in the DNA of breast cancer cells. Most of the breast cancers are diagnosed in women over age 50, but it’s not clear why some women get breast cancer and others do not. Some breast cancer risks may be preventable. Of course, you cannot control every variable that may influence your risk.

Breast Cancer 2021 gives an immaculate stage to bring out such quality research works. These gatherings are stretched out by commenting key administrative ranges like Multi-disciplinary Breast Cancer, Biological of Breast Cancer. Giving a possibility, Science Access breast cancer Conferences have researchers, analysts, substance associations and all agents of pharmaceutical and science organization divisions can exhibit their apt discoveries and in the meantime get presented to a helpful cluster of research and most recent improvements. This talk about the issues and achievements in the field of Breast Cancer Science Access Conferences has taken the start to accumulate the world-class specialists both from scholastic and industry in a typical stage at its Breast Cancer meetings with the Theme:Innovations and Novel Approaches in Diagnosis and Treatment of Breast Cancer and Women’s Health

Market Analysis

Breast cancer is the most commonly occurring cancer in women and the second most common cancer global. There were over 2 million new circumstances in 2018. The top 25 countries with the highest rates of breast cancer in 2018 are given in the table beneath.

As Per World Health Organization (WHO) statistics, about one-third of these cancer fatalities can be decreased through earlier detection and treatment. Early breast cancer treatment and detection have improved the five-year survival rate for women diagnosed with cancer to nearly 80%.

Breast cancer is the most common malignancy in women around the ecosphere. Information on the incidence and mortality of breast cancer is essential for planning wellbeing agencies. This study aimed to investigate the incidence and mortality of breast cancer in the world using age-specific occurrence and mortality rates for the year 2012 acquired from the global cancer project (GLOBOCAN 2012) as well as data about incidence and mortality of the cancer based on national news. It was estimated that 1,671,149 new cases of breast cancer were identified and 521,907 cases of deaths due to breast cancer occurred in the domain in 2012. According to GLOBOCAN, it is the most common cancer in women, accounting for 25.1% of all growths. Breast cancer incidence in developed countries is higher, while relative mortality is greatest in less developed kingdoms. Education of women is suggested in all countries for early detection and cure. Plans for the control and prevention of this cancer must be a high priority for health policy creators; also, it is necessary to increase awareness of risk factors and early detection in less developed countries.

Breast cancer is the most commonly occurring cancer in women accounting for 46,000 new cases in 2005. In 2003 there were an estimated 172,000 women living in the UK with a history of breast cancer. The rates have been steadily increasing over the past 10–15 years but they may now be stabilizing. Only a small number of cases, less than 1% of the total, occur in men. The numbers of cases of breast cancer are highest in the screened age group, 50 to 69 years, but the rates are highest in those aged over 85 years. It is estimated that 5% of women have metastases at diagnosis and a further 35% will develop them over the following 10 years. There is little geographical variation in the incidence rates across the country but rates are highest in those in higher socioeconomic groups. The incidence in the UK is higher than other countries, in particularly those in Eastern Europe and the risk of developing breast cancer appears to increase in those who move from a lower incidence country to the UK


Key players for Global Breast Cancer Market:

GlaxoSmithKline (UK), AstraZeneca (UK), Apthera Inc (UK), Pfizer (US), Novartis AG (Switzerland), BioNumerik Pharmaceuticals (US), Oncogenex (US), Oncothyreon Inc (US), Astellas (Japan), Bipar Sciences (US), Puma Biotechnology (US), Sanofi S.A. (US), Eli Lilly and Company (US), F. Hoffmann-La Roche (Switzerland), , Genentech (US), Teva Pharmaceutical Industries (Israel), Sun Pharmaceutical Industries Ltd (India), Accord Healthcare, Inc. (India), Gilead Sciences, Inc. (US), Bristol-Myers Squibb company (US), Actavis, Inc. (the US), Hospira, Inc. (the US), Bayer AG (Germany).Breast cancer screening market in Europe will be less than US$ 8 Billion by the end of the year 2022.

Breast cancer is one of the most dangerous diseases in the Europe region. Its incidence rate in Europe was 92.9 women per 100,000 women and mortality rate was 23.1 per 100,000 women. Hence, most of the countries of Europe has implemented or in the process to adopt breast cancer screening in their national cancer screening programs. Mammography screening is most commonly used as a breast cancer screening method in Europe.


UK Oncology Nursing Society, UK; The Breast Cancer Society of Canada, Canada; American Cancer Society, USA; National Breast Cancer Foundation (NBCF) Australia; New Zealand Breast Cancer Foundation, New Zealand; European Society for Medical Oncology , EUSOMA - European Society of Breast Cancer Specialists, Italy; The Breast Cancer Research Foundation, USA; Japanese Breast Cancer Society, Japan; Irish Cancer Society, Ireland; Austrian Cancer Society, Austria, German Cancer Society, Germany; Swedish Cancer Society, Sweden; European Association for Cancer Research (EACR); European Oncology Nursing Society (EONS); European Society of Surgical Oncology (ESSO); International Society of Paediatric Oncology (SIOP); Belgium Foundation Against Cancer; Cancer Society of Estonia; Cancer Society of Finland; German Cancer Research Center; Italian Cancer Patients Association; Norwegian Cancer Society; Spanish Association Against Cancer; Cancer Society of New Zealand.

Target Audience

Breast Cancer Surgeons, pathologists

Breast Care Nurse

Radiation Oncologist

Radiation Therapist

Medical Oncologist

Reconstructive (plastic) Surgeon

Lymphoedema Therapist

Nurse Practitioners/Nurses

Healthcare Faculty

Medical Colleges

Business Entrepreneurs

Training Institutes

Data Management Companies


Healthcare Associations and Societies

Manufacturing Medical Devices Companies

Worldwide Medicine universities

Harvard University

University of Minnesota

Mayo Medical School

Pittsburgh School of Medicine

Yale University

University of Cambridge

The University of Oxford Stanford University

Yale University

Emory University

John Hopkins University

Kings College London

Feinberg School of Medicine

University of Wisconsin

UNC School of Medicine

Karolinska University

The University of Tokyo

National University of Singapore (NUS)

Kyoto University

University of Hong Kong (HKU)

Peking University

Seoul National University (SNU)

National Taiwan University (NTU)

Osaka University






Target Audience

  • Presidents & CEO’s
  • Students
  • Surgeons
  • Nurses
  • Radiologists
  • Breast Cancer Biologist and oncologists

Contact Us

Feel Free To Contact Us

Address   : 2737 Live Oak Street, Huntington Park, CA 90255, USA
Phone No : +1-229-999-0040
Fax           : +1 - 267-646-2200
Email Id    :



Authorization Policy: By registering for the conference you grant permission to SCIENCEACCESS to photograph, film or record and use your name, likeness, image, voice, and comments and to publish, reproduce, exhibit, distribute, broadcast, edit and/or digitize the resulting images and materials in publications, advertising materials, or in any other form worldwide without compensation. Taking of photographs and/or video recording by participants/others during the conference is prohibited without prior approval. Contact us for any queries. Privacy is Everyone's Concern!